Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.
Eur J Immunol. 2011 Mar;41(3):787-97. doi: 10.1002/eji.201040591. Epub 2011 Feb 1.
B-cell-activating factor of the TNF family (BAFF)/BLyS contributes to B-cell homeostasis and function in the periphery. BAFF is expressed as a membrane-bound protein or released by proteolytic cleavage, but the functional importance of this processing event is poorly understood. Mice expressing BAFF with a mutated furin consensus cleavage site, i.e. furin-mutant BAFF (fmBAFF), were not different from BAFF-deficient mice with regard to their B-cell populations and responses to immunization. It is however noteworthy that an alternative processing event releases some soluble BAFF in fmBAFF mice. Mild overexpression (∼ 5-fold) of fmBAFF alone generated intermediate levels of B cells without improving humoral responses to immunization. Processed BAFF was however important for B-cell homeostasis, as peripheral B-cell populations and antibody responses were readily restored by administration of soluble BAFF trimers in BAFF-deficient mice. However, the rescue of CD23 expression in B cells of BAFF-deficient mice required both soluble BAFF trimers and fmBAFF, or a polymeric form of soluble BAFF (BAFF 60-mer). These results point to a predominant role of processed BAFF for B-cell homeostasis and function, and indicate possible accessory roles for membrane-bound BAFF.
B 细胞激活因子(TNF 家族)(BAFF)/BLyS 有助于外周血 B 细胞的稳态和功能。BAFF 以膜结合蛋白的形式表达或通过蛋白水解切割释放,但这种加工事件的功能重要性知之甚少。表达具有突变弗林蛋白酶共识切割位点的 BAFF(即弗林酶突变 BAFF(fmBAFF))的小鼠在 B 细胞群体及其对免疫的反应方面与 BAFF 缺陷型小鼠没有不同。然而,值得注意的是,替代加工事件会释放一些可溶性 BAFF 在 fmBAFF 小鼠中。fmBAFF 的轻度过表达(约 5 倍)单独产生中间水平的 B 细胞,而不会改善免疫接种的体液反应。然而,处理后的 BAFF 对于 B 细胞稳态很重要,因为可溶性 BAFF 三聚体在 BAFF 缺陷型小鼠中的给药可轻易恢复外周 B 细胞群体和抗体反应。然而,BAFF 缺陷型小鼠 B 细胞中 CD23 表达的恢复需要可溶性 BAFF 三聚体和 fmBAFF,或可溶性 BAFF 的聚合物形式(BAFF 60 聚体)。这些结果表明,加工后的 BAFF 在外周血 B 细胞稳态和功能中起主要作用,并表明膜结合 BAFF 可能具有辅助作用。
Eur J Immunol. 2011-2-1
Gene. 2012-5-12
Dev Comp Immunol. 2007
Int Immunopharmacol. 2011-10-25
Autoimmun Rev. 2008-2
Vet Immunol Immunopathol. 2009-7-15
Int J Mol Sci. 2024-9-26
Cancer Cell Int. 2021-4-17
Front Cell Dev Biol. 2020-11-6
Front Immunol. 2018-11-20